Zatebradine, a specific bradycardic agent, enhances the positive inotropic actions of dobutamine in ischemic myocardium
- 31 January 1994
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 23 (1) , 233-241
- https://doi.org/10.1016/0735-1097(94)90526-6
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Regional redistribution of myocardial perfusion by UL-FS 49, a selective bradycardic agentAmerican Heart Journal, 1992
- The effects of dopamine and dobutamine on regional function in the presence of rigid coronary stenoses and subcritical impairments of reactive hyperemiaAmerican Heart Journal, 1988
- Maximal coronary flow and the concept of coronary vascular reserve.Circulation, 1984
- Effects of three bradycardiac drugs on regional myocardial blood flow and function in areas distal to a total or partial coronary occlusion in dogs.Circulation, 1984
- Effects of inotropic and chronotropic stimuli on acute myocardial ischemic injury. I. Studies with dobutamine in the anesthetized dog.Circulation, 1982
- Significance of regional wall thickening abnormalities relative to transmural myocardial perfusion in anesthetized dogs.Circulation, 1980
- Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion.Circulation, 1979
- Dobutamine: A New Synthetic Cardioactive Sympathetic AmineNew England Journal of Medicine, 1979
- Influence of dobutamine on regional myocardial blood flow and ventricular performance during acute and chronic myocardial ischemia in dogs.Circulation, 1976
- Subendocardial ischemia provoked by tachycardia in conscious dogs with coronary stenosisThe American Journal of Cardiology, 1975